For the Inventor, By the Inventor

Enter assignee name

Beijing Mabworks Biotech Co. Ltd.

USPTO Granted Patents = 18

CIPO Patents = 1

EPO Patents = 2

Forward Citations = 15

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Feng Li (18 out of 141 patents)

Jiangmei Li (14 out of 14 patents)

Wenqi Hu (12 out of 12 patents)

4. Boyan Zhang (4 out of 8 patents)

5. Pei Ye (4 out of 4 patents)

6. Sijia Huang (3 out of 4 patents)

7. Chunyang Jin (3 out of 3 patents)

8. Jian Zhao (2 out of 42 patents)

9. Lun Jiang (2 out of 2 patents)

10. Fangjie Liu (2 out of 2 patents)

11. Yu Liu (1 out of 88 patents)

12. Xia Wang (1 out of 11 patents)

13. Wenqi Hu (1 out of 1 patent)

14. Boyan Zhang (0 patent)

15. Pei Ye (0 patent)

18 patents: Sort by Forward Citations

1. 12180280 - Antibodies binding human and monkey CD3 and uses thereof (2024-12-31),

2. 12084520 - Antibodies binding BCMA and CD3 and uses thereof (2024-09-10),

3. 11970541 - Anti-CD20 antibody (2024-04-30),

4. 11718674 - Antibodies binding PD-L1 and uses thereof (2023-08-08),

5. 11208492 - Anti-CD20 antibody (2021-12-28),

6. 11091558 - Anti-OX40 antibodies and uses thereof (2021-08-17),

7. 10946092 - Antibodies binding LAG3 and methods of treatment using them (2021-03-16),

8. 10662249 - Antibodies targeting CD40 and uses thereof (2020-05-26),

9. 10654939 - Antibodies specific to CD40 and uses thereof (2020-05-19),

10. 10654938 - CD40 binding antibodies and uses thereof (2020-05-19),

11. 10654937 - CD40 specific antibodies and uses thereof (2020-05-19),

12. 10647776 - Anti-CD40 antibodies and uses thereof (2020-05-12),

13. 10577424 - Antibodies binding VISTA and uses thereof (2020-03-03),

14. 10570210 - Antibodies binding CD40 and uses thereof (2020-02-25),

15. 10442866 - Antibodies binding OX40 and uses thereof (2019-10-15),

Beijing MabWorks Biotech Co. Ltd. is a leading biotechnology company based in Beijing, China. Specializing in the research, development, and production of innovative monoclonal antibody therapies for the treatment of various diseases, MabWorks is committed to improving global healthcare through their cutting-edge biotech solutions. With a team of highly skilled scientists and state-of-the-art facilities, the company aims to deliver safe, effective, and affordable therapies to patients worldwide. For more information about their groundbreaking work, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

18 Patents

#151 in Beijing

#1,441 in China

#33,177 in the World

Beijing Mabworks Biotech Co. Ltd.

Forward Citations = 15

13 inventors:

Feng Li (18 out of 141 patents)

Jiangmei Li (14 out of 14 patents)

Wenqi Hu (12 out of 12 patents)

4. Boyan Zhang (4 out of 8 patents)

5. Pei Ye (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…